medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/10.33667/2078-5631-2023-13-28-35medalphabet-3236Research ArticleСтатьиТревога и нарушения сна в общесоматической практикеAnxiety and sleep disorders in general practicehttps://orcid.org/0000-0003-0491-8823ПоляковаО. А.PolyakovaO. A.

Полякова Ольга Александровна, к.м.н., ассистент кафедры терапии и полиморбидной патологии имени академика М.С. Вовси

Москва

Polyakova Olga A., MD, PhD, Assistant Lecturer of the Department of Therapy andPolymorbid Pathology named after academician M.S. Vovsi

 Moscow 

docpolyakova.olga@gmail.comhttps://orcid.org/0000-0001-6573-4169ЭбзееваЕ. Ю.EbzeevaE. Yu.

Эбзеева Елизавета Юрьевна, к.м.н., доцент, доцент и зав. учебной частьюкафедры терапии и полиморбидной патологии имени академика М.С. Вовси

Москва

Ebzeeva Elizaveta Yu., MD, PhD, Associate Professor, Associate Professor and Head of education of the Department of Therapy and Polymorbid Pathology named after academician M. S. Vovsi

 Moscow 

veta-veta67@mail.ruhttps://orcid.org/0009-0008-6383-0016ДубининаА. В.DubininaA. V.

Дубинина Анна Владимировна, ординатор 2-го года обучения кафедры терапии и полиморбидной патологии имени академика М.С. Вовси

Москва

Dubinina Anna V., 2nd year resident of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi

Moscow

anutkaaadub@gmail.comhttps://orcid.org/0000-0003-1439-7371ТелковаС. С.TelkovaS. S.

Телкова Светлана Сергеевна, ординатор 2-го года обучения кафедры терапии и полиморбидной патологии имени академика М.С. Вовси

Москва

Telkova Svetlana S., 2nd year resident of the Department of Therapy andPolymorbid Pathology named after academician M.S. Vovsi

Moscow

svetlana.t03@yandex.ruhttps://orcid.org/0000-0002-2228-8442АсосковаА. В.AsoskovaA. V.

Асоскова Анастасия Валерьевна, ассистент кафедры дерматовенерологии и косметологии

Москва

Asoskova Anastasiia V., Assistant Lecturer of the Department of Dermatovenerology and Cosmetology

Moscow

stasya.asoskova@mail.ruhttps://orcid.org/0000-0001-7234-9525КозгуноваЛ. Д.KozgunovaL. D.

Козгунова Любовь Дмитриевна, студентка 6-го курса лечебного факультета

Москва

Kozgunova Lyubov D., 6th year student of the Faculty of Medicine

luba.kozgunova@mail.ruhttps://orcid.org/0000-0002-0795-8225ОстроумоваО. Д.OstroumovaO. D.

Остроумова Ольга Дмитриевна, д.м.н., проф., зав. кафедрой терапии и полиморбидной патологии имени академика М.С. Вовси

Москва

 

Ostroumova Olga D., MD, PhD, Professor, Head of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi

Moscow

 

Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian FederationRussian FederationФедеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian FederationRussian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Higher Education “A.I. Yevdokimov Moscow State University of Medicine and Dentistry” of the Ministry of Healthcare of the Russian FederationRussian Federation202318102023013Современная поликлиника (1)2835Copyright © Полякова О.А., Эбзеева Е.Ю., Дубинина А.В., Телкова С.С., Асоскова А.В., Козгунова Л.Д., Остроумова О.Д., 20232023Полякова О.А., Эбзеева Е.Ю., Дубинина А.В., Телкова С.С., Асоскова А.В., Козгунова Л.Д., Остроумова О.Д.Polyakova O.A., Ebzeeva E.Y., Dubinina A.V., Telkova S.S., Asoskova A.V., Kozgunova L.D., Ostroumova O.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3236

Тревога и нарушения сна являются актуальной проблемой современного здравоохранения, лечение которых необходимо проводить на максимально возможных ранних этапах, поскольку это позволит предотвратить развитие широкого спектра осложнений данных состояний. При этом, учитывая двунаправленную связь между тревогой и нарушениями сна, все большую актуальность приобретают поиск и разработка безопасных и эффективных средств для их коррекции. В качестве основных методов терапии тревожных расстройств и нарушений сна рассматривается назначение комплекса мероприятий немедикаментозного и медикаментозного характера. В данной работе представлены диагностические инструменты, позволяющие врачу общесоматической практики как можно раньше выявить тревогу и нарушения сна (инсомнии) у пациента, и обсуждены терапевтические стратегии применения комбинации глицина с мелатонином у соответствующих больных.

Anxiety and sleep disorders are an urgent problem of modern healthcare, which should be treated at the earliest possible stages, since this would prevent the development of a wide range of complications of these conditions. At the same time, given the bidirectional relationship between anxiety and sleep disorders, the search and development of safe and effective remedies for their correction is becoming increasingly relevant. The prescription of a set of measures of nonmedicamental and medicamental nature is considered to be the main methods of therapy for anxiety and sleep disorders. This article presents diagnostic tools that allow the general practitioner to identify anxiety and sleep disorders (insomnia) in a patient as early as possible, and discusses the therapeutic strategies for using a combination of glycine and melatonin in appropriate patients.

тревогатревожное расстройствонарушение снаинсомниямелатонинглицинanxietyanxiety disordersleep disordersinsomniamelatoninglycineReferencesSelye H. The story of the adaptation syndrome. Canada: Medical Publishers, 1952. 225 p.Selye H. The story of the adaptation syndrome. Canada: Medical Publishers, 1952. 225 p.Котова О.В., Акарачкова Е.С., Беляев А.А. Психовегетативный синдром: трудности диагностики и эффективного лечения // Медицинский совет. 2018;18(21):50–55. https://doi. org/10.21518/2079–701X 2018–21–50–55Kotova O.V., Akarachkova E.S., Belyaev A.A. Psychovegetative syndrome: diagnosis and diagnosis of treatment. Meditsinskiy Sovet. 2018;18(21):50–55. (In Russ.). https://doi. org/10.21518/2079–701X 2018–21–50–55Эбзеева Е.Ю., Полякова О.А. Тревожные расстройства и нарушения сна // Медицинский совет. 2022;16(11):108–113. https://doi.org/10.21518/2079–701X 2022–16–11–108–113Ebzeeva E. Yu., Polyakova O. A. Anxiety and sleep disorders. Meditsinskiy Sovet. 2022;16(11):108–113. (In Russ.). https://doi.org/10.21518/2079–701X 2022–16–11–108–113Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry. 2006;51(2):100–113. https://doi.org/10.1177/070674370605100206Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry. 2006;51(2):100–113. https://doi.org/10.1177/070674370605100206Martín-Merino E, Ruigómez A, Wallander MA. et al. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam. Pract. 2010;27(1):9–16. https://doi.org/10.1093/fampra/cmp071Martín-Merino E, Ruigómez A, Wallander MA. et al. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam. Pract. 2010;27(1):9–16. https://doi.org/10.1093/fampra/cmp071Остроумова Т.М., Парфенов В.А., Остроумова О.Д. и др. Артериальная гипертензия и инсомния // Терапевтический архив. 2020;92(1):69–75. https://doi.org/10.26442/00403660.2 020.01.000319Остроумова Т.М., Парфенов В.А., Остроумова О.Д. и др. Артериальная гипертензия и инсомния // Терапевтический архив. 2020;92(1):69–75. https://doi.org/10.26442/00403660.2 020.01.000319Morphy H, Dunn KM, Lewis M. et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–280. https://doi.org/10.1093/sleep/30.3.274Morphy H, Dunn KM, Lewis M. et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–280. https://doi.org/10.1093/sleep/30.3.274Wilson S, Anderson K, Baldwin D. et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J. Psychopharmacol. 2019;33(8):923–947. https://doi.org/10.1177/0269881119855343Wilson S, Anderson K, Baldwin D. et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J. Psychopharmacol. 2019;33(8):923–947. https://doi.org/10.1177/0269881119855343Staines AC, Broomfield N, Pass L. et al. Do non-pharmacological sleep interventions affect anxiety symptoms? A meta-analysis. J. Sleep. Res. 2022;31(1): e13451. https://doi. org/10.1111/jsr.13451Staines AC, Broomfield N, Pass L. et al. Do non-pharmacological sleep interventions affect anxiety symptoms? A meta-analysis. J. Sleep. Res. 2022;31(1): e13451. https://doi. org/10.1111/jsr.13451Cox R. C., Olatunji B. O. A systematic review of sleep disturbance in anxiety and related disorders. J. Anxiety. Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001Cox R. C., Olatunji B. O. A systematic review of sleep disturbance in anxiety and related disorders. J. Anxiety. Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001Stein M.B., Enns M.W., Kryger M.H. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J. Affect. Disord. 1993;28(1):1–6. https://doi.org/10.1016/0165–0327(93)90071-qStein M.B., Enns M.W., Kryger M.H. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J. Affect. Disord. 1993;28(1):1–6. https://doi.org/10.1016/0165–0327(93)90071-qAlfano C.A., Patriquin M.A., De Los Reyes A. Subjective – objective sleep comparisons and discrepancies among clinically-anxious and healthy children. J. Abnorm. Child. Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802–015–0018–7Alfano C.A., Patriquin M.A., De Los Reyes A. Subjective – objective sleep comparisons and discrepancies among clinically-anxious and healthy children. J. Abnorm. Child. Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802–015–0018–7Soehner AM, Harvey AG. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample. Sleep. 2012;35(10):1367–1375. https://doi.org/10.5665/sleep.2116Soehner AM, Harvey AG. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample. Sleep. 2012;35(10):1367–1375. https://doi.org/10.5665/sleep.2116Foley JE, Weinraub M. Sleep, Affect, and Social Competence from Preschool to Preadolescence: Distinct Pathways to Emotional and Social Adjustment for Boys and for Girls. Front Psychol. 2017;8:711. https://doi.org/10.3389/fpsyg.2017.00711Foley JE, Weinraub M. Sleep, Affect, and Social Competence from Preschool to Preadolescence: Distinct Pathways to Emotional and Social Adjustment for Boys and for Girls. Front Psychol. 2017;8:711. https://doi.org/10.3389/fpsyg.2017.00711Lovato N, Gradisar M. A meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practice. Sleep. Med. Rev. 2014;18(6):521–529. https://doi.org/10.1016/j.smrv.2014.03.006Lovato N, Gradisar M. A meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practice. Sleep. Med. Rev. 2014;18(6):521–529. https://doi.org/10.1016/j.smrv.2014.03.006McMakin DL, Alfano CA. Sleep and anxiety in late childhood and early adolescence. Curr. Opin. Psychiatry. 2015;28(6):483–489. https://doi.org/10.1097/YCO.0000000000000204McMakin DL, Alfano CA. Sleep and anxiety in late childhood and early adolescence. Curr. Opin. Psychiatry. 2015;28(6):483–489. https://doi.org/10.1097/YCO.0000000000000204LeBlanc M, Mérette C, Savard J. et al. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027–1037. https://doi.org/10.1093/sleep/32.8.1027LeBlanc M, Mérette C, Savard J. et al. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027–1037. https://doi.org/10.1093/sleep/32.8.1027Taylor D.J., Mallory L.J., Lichstein K.L. et al. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213Taylor D.J., Mallory L.J., Lichstein K.L. et al. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873–880. https://doi.org/10.1093/ sleep/30.7.873Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873–880. https://doi.org/10.1093/ sleep/30.7.873Драпкина О.М., Концевая А.В., Калинина А.М. и др. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):5–232. https://doi.org/10.15829/1728– 8800–2022–3235Drapkina O. M., Kontsevaya A. V., Kalinina A. M. et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):5–232. (In Russ.). https://doi.org/10.15829/1728– 8800–2022–3235Есин Р.Г., Есин О.Р., Хакимова А.Р. Стресс-индуцированные расстройства // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(5):131–137. https://doi.org/10.17116/ jnevro2020120051131Esin R.G., Esin O.R., Khakimova A.R. Stress-induced disorders. Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova. 2020;120(5):131–137. (In Russ.). https://doi.org/10.17116/ jnevro2020120051131Тревожно-фобические расстройства. Клинические рекомендации, утвержденные Минздравом России (2021). Режим доступа: https://cr.minzdrav.gov.ru/recomend/455_2Anxiety-phobic disorders. Clinical recommendations approved by the Ministry of Health of Russia (2021). (In Russ.). Режим доступа: https://cr.minzdrav.gov.ru/recomend/455_2Сомнология и медицина сна: Национальное руководство памяти А.М. Вейна и Я.И. Левина / под ред. М.Г. Полуэктова. М.: Мед-форум, 2016. 660 с.Somnology and Sleep Medicine: National Manual in Memory of A.M. Vein and J.I. Levin. Edited by M.G. Poluektov. Moscow: Med-forum, 2016. 660 p. (In Russ.).Ковальзон В.М. Основы сомнологии: физиология и нейрохимия цикла «бодрствование–сон». М.: БИНОМ. Лаборатория знаний, 2012. 239 с.Kovalson V.M. Fundamentals of somnology: physiology and neurochemistry of the «waking–sleep» cycle. Moscow: BINOM. Laboratory of Knowledge, 2012. 239 p. (In Russ.)Остроумова О.Д., Кочетков А.И., Эбзеева Е.Ю. и др. Инсомния и полиморбидность: учеб. пособие. М.: ФГБОУ ДПО РМАНПО Минздрава России, 2021. 76 с.Ostroumova O.D., Kochetkov A.I., Ebzeeva E.Yu. et al. Insomnia and polymorbidity: a training manual. Moscow: Russian Ministry of Health, 2021. 76 p. (In Russ.).Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14–0970Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14–0970Шишкова В.Н., Нарциссов Я. Р., Титова В.Ю. и др. Молекулярные механизмы, определяющие применение комбинации глицина и цинка в коррекции основных проявлений стресса и тревоги // Фармация и фармакология. 2022;10(5):404–415. https://doi. org/10.19163/2307–9266–2022–10–5–404–415Shishkova V.N., Nartsissov Ya.R., Titova V.Yu. et al. Molecular mechanisms defining application of glycine and zinc combinationin correction of stress and anxiety main manifestations. Pharmacy & Pharmacology. 2022;10(5):404–415. (In Russ.). https://doi. org/10.19163/2307–9266–2022–10–5–404–415Karna B, Sankari A, Tatikonda G. Sleep Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 26, 2023.Karna B, Sankari A, Tatikonda G. Sleep Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 26, 2023.Godos J, Currenti W, Angelino D. et al. Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms. Antioxidants (Basel). 2020;9(4):346. https://doi. org/10.3390/antiox9040346Godos J, Currenti W, Angelino D. et al. Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms. Antioxidants (Basel). 2020;9(4):346. https://doi. org/10.3390/antiox9040346File SE, Fluck E, Fernandes C. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults. J. Clin. Psychopharmacol. 1999;19(6):506–512. https://doi.org/10.1097/00004714–199912000–00004File SE, Fluck E, Fernandes C. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults. J. Clin. Psychopharmacol. 1999;19(6):506–512. https://doi.org/10.1097/00004714–199912000–00004Inagawa K, Hiraoka T, Kohda T. et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. 2006;4(1):75–77. https://doi. org/10.1111/j.1479–8425.2006.00193.xInagawa K, Hiraoka T, Kohda T. et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. 2006;4(1):75–77. https://doi. org/10.1111/j.1479–8425.2006.00193.xYamadera W, Inagawa K, Chiba S. et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126–131. https://doi.org/10.1111/j.1479–8425.2007.00262.xYamadera W, Inagawa K, Chiba S. et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126–131. https://doi.org/10.1111/j.1479–8425.2007.00262.xInagawa K, Kawai N, Ono K. et al. Assessment of acute adverse events of glycine ingestion at a high dose in human volunteers. J. Urban. Living. Health Assoc. 2006;50:27–32.Inagawa K, Kawai N, Ono K. et al. Assessment of acute adverse events of glycine ingestion at a high dose in human volunteers. J. Urban. Living. Health Assoc. 2006;50:27–32.Razak MA, Begum PS, Viswanath B. et al. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid. Med. Cell. Longev. 2017;2017:1716701. https://doi. org/10.1155/2017/1716701Razak MA, Begum PS, Viswanath B. et al. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid. Med. Cell. Longev. 2017;2017:1716701. https://doi. org/10.1155/2017/1716701Pérez-Torres I, Zuniga-Munoz AM, Guarner-Lans V. Beneficial Effects of the Amino Acid Glycine. Mini Rev. Med. Chem. 2017;17(1):15–32. https://doi.org/10.2174/1389557516666160609081602Pérez-Torres I, Zuniga-Munoz AM, Guarner-Lans V. Beneficial Effects of the Amino Acid Glycine. Mini Rev. Med. Chem. 2017;17(1):15–32. https://doi.org/10.2174/1389557516666160609081602Bartlett DJ, Biggs SN, Armstrong SM. Circadian rhythm disorders among adolescents: assessment and treatment options. Med. J. Aust. 2013;199(8): S16–S20. https://doi. org/10.5694/mja13.10912Bartlett DJ, Biggs SN, Armstrong SM. Circadian rhythm disorders among adolescents: assessment and treatment options. Med. J. Aust. 2013;199(8): S16–S20. https://doi. org/10.5694/mja13.10912Takaesu Y, Futenma K, Kobayashi M. et al. A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit. Chronobiol. Int. 2015;32(6):875–879. https://doi.org /10.3109/07420528.2015.1048869Takaesu Y, Futenma K, Kobayashi M. et al. A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit. Chronobiol. Int. 2015;32(6):875–879. https://doi.org /10.3109/07420528.2015.1048869Xie Z, Chen F, Li WA. et al. A review of sleep disorders and melatonin. Neurol. Res. 2017;39(6):559–565. https://doi.org/10.1080/01616412.2017.1315864Xie Z, Chen F, Li WA. et al. A review of sleep disorders and melatonin. Neurol. Res. 2017;39(6):559–565. https://doi.org/10.1080/01616412.2017.1315864Geoffroy PA, Etain B, Franchi JA. et al. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr. Pharm. Des. 2015;21(23):3352–3358. https://doi.or g/10.2174/1381612821666150619093448Geoffroy PA, Etain B, Franchi JA. et al. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr. Pharm. Des. 2015;21(23):3352–3358. https://doi.or g/10.2174/1381612821666150619093448Galley HF, Lowes DA, Allen L. et al. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J. Pineal. Res. 2014;56(4):427–438. https://doi.org/10.1111/jpi.12134Galley HF, Lowes DA, Allen L. et al. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J. Pineal. Res. 2014;56(4):427–438. https://doi.org/10.1111/jpi.12134Chang YS, Lin MH, Lee JH. et al. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42. https://doi.org/10.1001/jamapediatrics.2015.3092Chang YS, Lin MH, Lee JH. et al. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42. https://doi.org/10.1001/jamapediatrics.2015.3092Lähteenmäki R, Puustinen J, Vahlberg T. et al. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. Br.J. Clin. Pharmacol. 2014;77(6):975–985. https://doi.org/10.1111/bcp.12294Lähteenmäki R, Puustinen J, Vahlberg T. et al. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. Br.J. Clin. Pharmacol. 2014;77(6):975–985. https://doi.org/10.1111/bcp.12294Amstrup AK, Sikjaer T, Mosekilde L. et al. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr. J. 2015;14:102. https://doi.org/10.1186/s12937–015–0093–1Amstrup AK, Sikjaer T, Mosekilde L. et al. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr. J. 2015;14:102. https://doi.org/10.1186/s12937–015–0093–1Scheer FA, Morris CJ, Garcia JI. et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–1402. https://doi.org/10.5665/sleep.2122Scheer FA, Morris CJ, Garcia JI. et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–1402. https://doi.org/10.5665/sleep.2122Gumenyuk V, Belcher R, Drake CL. et al. Differential sleep, sleepiness, and neurophysiology in the insomnia phenotypes of shift work disorder. Sleep. 2015;38(1):119–126. https://doi.org/10.5665/sleep.4336Gumenyuk V, Belcher R, Drake CL. et al. Differential sleep, sleepiness, and neurophysiology in the insomnia phenotypes of shift work disorder. Sleep. 2015;38(1):119–126. https://doi.org/10.5665/sleep.4336Kaminski RS, Martinez D, Fagundes M. et al. Melatonin prevents hyperglycemia in a model of sleep apnea. Arch. Endocrinol. Metab. 2015;59(1):66–70. https://doi. org/10.1590/2359–3997000000012Kaminski RS, Martinez D, Fagundes M. et al. Melatonin prevents hyperglycemia in a model of sleep apnea. Arch. Endocrinol. Metab. 2015;59(1):66–70. https://doi. org/10.1590/2359–3997000000012Xie S, Deng Y, Pan YY– et al. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5’ adenosine monophosphate-activated protein kinase pathway. Biochem. Biophys. Res. Commun. 2015;464(4):975–981. https://doi.org/10.1016/j.bbrc.2015.06.149Xie S, Deng Y, Pan YY– et al. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5’ adenosine monophosphate-activated protein kinase pathway. Biochem. Biophys. Res. Commun. 2015;464(4):975–981. https://doi.org/10.1016/j.bbrc.2015.06.149Yeung HM, Hung MW, Lau CF. et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J. Pineal Res. 2015;58(1):12–25. https://doi.org/10.1111/jpi.12190Yeung HM, Hung MW, Lau CF. et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J. Pineal Res. 2015;58(1):12–25. https://doi.org/10.1111/jpi.12190Abadir PM, Periasamy A, Carey RM. et al. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension. 2006;48(2):316–322. https://doi. org/10.1161/01.HYP.0000228997.88162.a8Abadir PM, Periasamy A, Carey RM. et al. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension. 2006;48(2):316–322. https://doi. org/10.1161/01.HYP.0000228997.88162.a8Sabatini RA, Guimarães PB, Fernandes L. et al. ACE activity is modulated by kinin B2 receptor. Hypertension. 2008;51(3):689–695. https://doi.org/10.1161/HYPERTENSIONAHA.107.091181Sabatini RA, Guimarães PB, Fernandes L. et al. ACE activity is modulated by kinin B2 receptor. Hypertension. 2008;51(3):689–695. https://doi.org/10.1161/HYPERTENSIONAHA.107.091181

The authors declare that there are no conflicts of interest present.